GLP-1s May Protect Against Stroke and Alzheimer’s Disease
GLP-1 (glucagon-like peptide-1) medications may offer protective benefits against stroke and Alzheimer’s disease. Emerging research suggests these drugs, commonly used for diabetes, could help reduce the risk or severity of these neurological conditions by improving brain health and vascular function. This potential dual benefit highlights the importance of further studies on GLP-1 therapies beyond diabetes management.
EMJ·